1 / 15

In vitro evaluation of a multifunctional bactericidal synthetic bone substitute

In vitro evaluation of a multifunctional bactericidal synthetic bone substitute. D. Bollati , M. Morra, C. Cassinelli, G. Cascardo Nobil Bio Ricerche srl, Via Valcastellana 26, 14037 Portacomaro (AT) Italy. www.nobilbio.it dbollati@nobilbio.it. Baveno, SIB Conference, 3-5 June 2013.

rupert
Download Presentation

In vitro evaluation of a multifunctional bactericidal synthetic bone substitute

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. In vitro evaluation of a multifunctional bactericidal synthetic bone substitute D. Bollati, M. Morra, C. Cassinelli, G. Cascardo Nobil Bio Ricerche srl, Via Valcastellana 26, 14037 Portacomaro (AT) Italy www.nobilbio.it dbollati@nobilbio.it Baveno, SIB Conference, 3-5 June 2013

  2. Outline • Introduction • Goal of the study • Materials and methods • Results • Comments and conclusions Baveno, SIB Conference, 3-5 June 2013

  3. Introduction: bone substitutes Powder, granules or scaffolds used to fill up bone pits in different applications: - maxillofacial - dental - prosthetic surgery - spinal surgery • These materials could be synthetic or of animal/human source ; • a synthetic bone substitute should be biocompatible, osteoconductive and possibly osteoinductive; • often used in presence of infections antibiotic delivery in the implant site Baveno, SIB Conference, 3-5 June 2013

  4. Bone formation at the interface with tissue Prevention of bacteria colonization Goal of the study Development of an innovative process of surfacemodification on a synthetic phosphatic bone substitute: ‘’Multifunctional’’ synthetic bone substitute Baveno, SIB Conference, 3-5 June 2013

  5. 1 mm 10 µm Materials and methods Symbol Formula Ca/P - β-TCP 75% - nano HAP 25% HAP Ca10(PO4)6(OH)2 1,67 - Granules dimensions: 300 μm/ 2 mm Β-TCP Ca3(PO4)2 1,5 Baveno, SIB Conference, 3-5 June 2013

  6. ~ 200 nm Materials and methods Surface modification ‘’CVHA’’ collagen 1. Collagen fibrillation with vancomycin and hyaluronic acid; vancomycin 2. covalent linking of hyaluronic acid; hyaluronic acid 3. interaction of vancomycin with HA and crosslinking. βTCP/HAP granules Baveno, SIB Conference, 3-5 June 2013

  7. Ctrl “CVHA” Staph. Epidermidis growth is inhibited by vancomycin release from the granules Results: anti-bacterial effect ‘’Agar germ’’ experiments Baveno, SIB Conference, 3-5 June 2013

  8. Most of antibiotic is released within 3 days Results: anti-bacterial effect Vancomycin release Baveno, SIB Conference, 3-5 June 2013

  9. “Osteoimmunology: crosstalk between the immune and bone system” T. Nakashima, H. Takayanagi ; J Clin Immunol (2009) 29:555–567 Gene expression analysis of macrophages and osteoblasts Results: biological response • bone formation depends on the balancing between osteoblast and osteoclast activity • osteoclast differentiation is enhanced by several cytokines produced by inflammatory cells and by specific signal molecules produced by monocytes and osteoblasts Baveno, SIB Conference, 3-5 June 2013

  10. - MCP-1 - IL-1β - IL-6 - IL-10 1) M.Rauner et al “Osteoimmunology” Int. Arch. Allergy Immunol. 2007,143, 31-48 2) K. Steeve et al. “IL-6, RANKL, TNF alpha/IL1: interrelations in bone resorption pathophysiology” Cytokine and Growth Factor Reviews, 15 (2004), 49-60 Results: biological response (macrophages) Gene expression of J774A.1 macrophages Expression of these genes at different timepoints Pro-inflammatory mediators, stimulate bone resorption, osteoclast formation, RANKL signaling and are involved in the response to bacteria and endotoxins Anti-inflammatory mediator Baveno, SIB Conference, 3-5 June 2013

  11. 4h 24h Ctrl CVHA Results: biological response (macrophages) Gene expression of J774A.1 macrophages Baveno, SIB Conference, 3-5 June 2013

  12. - ALP - OCN - BSP - RANKL - OPG 1) M.Rauner et al “Osteoimmunology” Int. Arch. Allergy Immunol. 2007,143, 31-48 2) K. Steeve et al. “IL-6, RANKL, TNF alpha/IL1: interrelations in bone resorption pathophysiology” Cytokine and Growth Factor Reviews, 15 (2004), 49-60 3) V. Pivodova et al. “Osteoblast and gingival fibroblast markers in dental implant studies” Biomed. Pap. Med. 2011, June, 155(2) 109-116 Results: biological response (osteoblasts) Gene expression of SaOs-2 osteoblasts Expression of these genes at different timepoints Pro-osteogenic markers, generate free phosphates, involved in bone mineralization and calcium binding action RANK receptor,induces differentitation of pre-osteoclasts to osteoclasts Soluble RANK, its interaction with RANKL inhibits osteoclast formation Baveno, SIB Conference, 3-5 June 2013

  13. 24h 72h Ctrl CVHA Results: biological response (osteoblasts) Gene expression of SaOs-2 osteoblasts Baveno, SIB Conference, 3-5 June 2013

  14. osteoblasts monocytes ALP, BSP IL-1, IL-6, MCP-1 RANKL IL-10 differentiation osteoclasts Results: biological response ‘’CVHA’’ surface modification could affect bone remodeling mechanisms Baveno, SIB Conference, 3-5 June 2013

  15. Comments and conclusions • a synthetic biphasic bone substitute was developed • surface modification with collagen, vancomycin and hyaluronic acid (stable even after γ sterilization) • antibiotic release is immediate and effective to inhibit bacterial growth in vitro • the presence of collagen and hyaluronic acid seems to shift the balance of bone remodeling towards bone formation, instead of its resorption • this multifunctional product could help to meet several clinical needs Thank you for attention Baveno, SIB Conference, 3-5 June 2013

More Related